Skip to main content
. 2023 Dec 8;39(1):e8. doi: 10.3346/jkms.2024.39.e8

Fig. 1. Comparison of background medical therapies. Background medical therapies were compared between EMPEROR-Reduced, EMPEROR-Preserved trial, and KorAHF registry.

Fig. 1

ACEI = angiotensin-converting enzyme inhibitor, ARB = angiotensin receptor blocker, β-blocker = beta-blocker, EMPEROR-Preserved = EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction, EMPEROR-Reduced = EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction, HFpEF = heart failure with preserved ejection fraction, HFrEF = heart failure with reduced ejection fraction, KorAHF = Korean Acute Heart Failure, MRA = mineralocorticoid receptor antagonist.